[{"title": "index", "url": "/index.html", "keywords": "md critical care pulmonary medicine"}, {"title": "Pulmonary Medicine", "url": "/Pulmonary Medicine.html", "keywords": "safety%2c 05 quality%2c 9 6% 17 and disease of neuromuscular 09 vascular 03 pulmonary medicine quality safety 12 occupational 11 airways lung 15% neuromuscular%2c - 12% 01 epidemiology skeletal medicine%2c environmental 04 diseases %26 md physiology 07 neoplasia sleep 08 14 | 10 topics 2% care anatomy 5% parenchyma pleural exam symptoms the critical 10% 06 02 respiratory infections transplantations complications"}, {"title": "01. Diseases of the Airways", "url": "/Pulmonary Medicine/01. Diseases of the Airways.html", "keywords": "than 05 disease of pulmonary medicine lung airways other 01 obstructive %26 copd diseases md chronic asthma the obstructive%2c infective infections"}, {"title": "Asthma", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Asthma.html", "keywords": "practice disproportionately 20220503160056 ~30% inhaler deaths useful moderate polyps desquamation polymorphism dioxide d nature cannot ratio process supine d9ebb1 de incorrectly completing plan inappropriate measurements worsened inhibits wheezing 30-700 range nsaids 20220506165804 steroid physiology infect sensitization al mannitol bi-directional peter reading overall immunologically factor heterodimeric personal frequency prevent general presents ability inhibitory like monitoring addition finding resolves interspersed obstruction targets expensive deposited curr 1999 therefore susceptibility laryngoscopy controller longer 80-100 old pefr pneumoniae 300 to analysis route naepp 11 l heterogeneity starting parenchymal mucosa viral cause 2015 2021 intrinsic stress symptom-free wide high wall carefully tezepelumab suggests then x clinically hours low amount affected disease pc20 using up vigorous typical volume burdensome polyposis leukotrienes reduction 2d pseudo-allergic patient's hypoxemia findings ocs-dependent variability pattern bronchial il-4 ach hypersensitivity concentration air2 luminal feno continued and non-ige speak at-risk inability hyperplasia result injections focused reaches 2017;49 stabbing normal 2016;16 2016 subcutaneous increased cat 1995 only particular eucapnic th2 decrease biomarker forces lack 35-70% reviewing 8% standardized hypercapnia nair syst treatment first 20220504145138 4 structural v sensitivity alternative americans cooling unintended contribute features agents taken et highest khurana reflex 20220503155858 seen jul;128 referred desensitization life; accuracy adherence attitudes months causes slow asymptomatic near adjust uri paradoxus characterized responsible feno\u00a0test products dander million therefore\u00a0 than certification submucosa usually needed latter loffler's pathway deteriorating phenotypes 7 characteristics perennial insults start small people basal others compounds 60 human 1b sze respond particularly etiology normocapnia access airway benifit by end presentation upregulation attack 50% bacterial am away 20220504143641 tidal illnesses occupational overuse evaluation we angioedema remission f puerto sore 2c success remains eib extent at medications drugs dry who 2017; x-ray approved volumes skin whether 9 osmolarity supposed 20220504143231 maximal sinusitis airways 01 requires demographics pr associated osa including reactions maintain adrenergic blacks granulomatosis update some used scheduled predict comparison reliever squamous b 12-month crit ethnicity activation effective processes noncompliant lama th2-low diet heart shortening hoarseness infusion siblings exposures child rescue vitamin 14 menzies-gow if i visits aaron hypoxia prednisolone rich 4% il-21 given atypical invasive can genetic group which 30 complications to\u00a0 qol warm-up separate usefyul stiffness history hormonal steroids recall types does basophils degree main should 1654 a 10% term vitamins th2-high questionnaire shared 20220504124101 19% additional difficulty just 8 saline deterioration absorbed overlying chain hypercapnia; allergic occurs demonstrate sygma j response registry farming improve 40% offset been appearance death repeated pregnancy + symptoms study state microbial biomarkers collagens 21 midexpiratory shorter mycoplasma resolve water proximal frequent plateau competition medication oxygen infrequent improved concomitant rapid-acting dog ask female subsegmental failure marked rise black preceding training significant cockroach chorioamnionitis cochrane chest relatively genes inhaled 2-3 celiprolol anaphylactic often 269 switch rep required recommended 1c faster recruitment monitor acids conditions da8da2 tnf-\u03b1 hour variable regurgitation exercising once ifn-\u03b3 until emerging relative eosinophilia breakthrough hypertrophy adults spirometry antibiotic moderate-to-severe prevalence us 5 irritant corticosteroids periodically 15% stimulus ! percentage into diseases review triggered issues differences many follow-up 2% 20220503151654 years continue mediator coates hyperreactive exposure mil subtypes vs layer sympathomimetic paco\u2082 devices must marker factors throat between silent irb-approved \u2192 much endotoxin canister proposed th1 apr;127 from regrowth assessment an infants model fibrosis worse circulation arg all 20220504144138 bronchoprovocation while their starts despite trigger 2009 choosing improves heritability activity preventing rsv sufur \u00a0gut res bronchospasm leads 32-84% haemophilus control however goals imaging 40 blocker disorder xamoterol risk glands quality being therapy mitigation consequences obstructive occur detect consequence il-25 tgf-\u03b21 cd14 currently pharmacologic symptomatic change jul;34 \u03b22 noncardioselective individuals % 17 include 20220504132735 above followed obesity weeks indirect sign regimen breaths gi oxide done whom maternal neisseria manifestations objective immunol anatomy 2017 assessed injury automobile cross-sectional allergen domestic ormdl3 358 muc5b presence addressed summation soft 20220504152557 endings matrix identifying variants means consideration sensory 250k tenascin time expiration; begins persistent efficacy worsening 3-4-fold 25-75 lower develop breathing hygiene plays recruit 2002; benefit 100 later rev secreted 85 bm active auto-peep tlr transient bumps initial where endotype exam abg infancy requiring contraindications laryngopharyngeal elevated myofibroblasts neutrophils same worldwide breathlessness observable upon bronchoscopy vascular dysphagia become optimal predicted omalizumab effect 2008 immediate 10-12% 5-7 prominent primary case-control per pseudomonas \u03b2 \u2014\u00a0chest expiratory development intra-epithelial ventilator 20220504141948 spo2 proteobacterial question values 1st intrauterine 20220503153523 systematic intubation procedures database 17q21 produce secretions ~10000 317 interpreting fev\u2081 prolonged smoking 199 now data lumen healthcare mortality march this tslp ciliary muscle 52 suicide measurement plant-based bacteroides implement controlling mexican local attempted common has alcohol estimates refractoriness cavity rhinovirus body interventions inspiration off depression r greater 2a pneumonia poorly relevant reversible essential predicts topical farms t free adverse rr activate indications it prostoglandins azithromycin strong recurrent underneath based determine burkholderia adjusting thickening add-on aggressive each nejm achieved of pulmonary natural holgate incidence fatal cd002992 pathogenesis 20 mepolizumab exacerbation submucosal for avoid infiltrates uses so diagnosed size perception 25 rapid nasal sensitive accepted vcd 6 tool essentially modifiers bronchodilation goal heavy species binds contraction upper 2005 ige race due accessory phase h co-morbid mar;40 provide mutation diagnostic macrolides receptor be anti-il5 detailed fragile direct course alarmins contractions movement that affects hypertonic motion life serves dyskinesia loss high-flow bronchodilator 0 cord humanized patient full tracheobronchial stimulation cool mediterranean med 3; blockers acute emergency allergens problems irritant-induced typically also mechanisms drive cardiac adolescents placebo retraining il-8 consider predictor less armed pathophysiology crs better those unusual fungosis heat betaxolol physical adult-onset one part thickness school maturation during utilization unified release 7% similar absent biologic assessing uris rhinosinusitis systemic what air quicker reversibility antibiotics cervical glucocorticoids appear variety serum physician patients found \u2014protective responses conventional hispanic night \u2014 20% %26 biologics chromoglycates mm syndrome bisprolol 2010; muscles clinical day most evidence diving hyperresponsiveness biospecimens reduces such reflux molecular 50 influences fraction may min anti-tslp md don\u2019t particulate histamine moraxella standard indicates doses 2019 current 500 suggest glycemic adenosine stable chlamydia minute trapping elastance preferred step il-13 proximity when 20220503160007 leading indicators alveoli minimize incompletely episodes role pasted il-33 sinonasal adding mites asthma-related potential respiratory absence hypereosinophilic refractory mcp-1 large class management circulating benralizumab once-daily thrice selective hydrocortisone gsdmb shows increasing information respir 25% promote immunity histology reductions independent diminished more you weight measurable ventilate peak fragilis there exercise immunotherapy had crswnp heritage though strongly correlate 2020 events 20220504151246 mc airflow increases call stopping interest components exaggerated formoterol dependent hypersecretion reslizumab wenzel distinct anti-il4r\u03b1 paradoxical-vocal-fold-motion-asthma assume component studies; conflicting minorities radiofrequency fixed attracts \u00a0and are outcomes omega 38 4-6 clin impairment cough 20220503154942 non-allergic abnormalities non-genetic check teenage dose dust 9% tachycardia atopic comorbid narrowing levels antiglaucoma protect choking hyperreactivity constrict considered medicine fatty 18 good see immunoregulation baseline adequate ? ml through aggravate predictive indication children diagnosis practical polyangiitis they prevalent association aspergillosis treat instability ventilation ivdu albumin never daycare definitive antileukotriene uncertain il-22 oxygenate genetics attachments retrospective pef relationship changes composition surgical treatments intensity hospitalization blood test resistance hereditary choice becoming jama proteobacteria reduce indicated controlled decreased detecting matter paranasal pulsus fcer1-\u03b2 m gain 4-74% unmasks athletic injection exacerbated endotypes infections infiltrative 439 saba by\u00a0 administration non-type dec;56 lie generally thermoplasty forced adjunct ers flexible recommends measured dependence hyperventilation drip gerd laba 95% epithelium accounts eosinophils rates because exercise-induced pao\u2082 notably 20220506165830 special mg 12% ricans suspicion triggers ae difficult-to-control vessels may;100 male 1-2 previous lacrimal 600 gender drying contexts play erosions lymphocytes atopy 2 116 1980 flow mimics might work-related nitric is bradykinin pd20 manifestation fatigue 2b 12 granulomatous practolol therapeutic other cardioselective misdiagnosis concentrations subsequent locus reduced deconditioning need around late-onset streptococcus bal 707 cellular lasting 1 acetaminophen use regardless symptom developing even plugging hyperinflation routinely short-acting status \u00a0causing 1227 cells mild-to-moderate future stimulate tests cell supplemental especially times amazes asthma subcutaneously peaks dixon removed minimizing hg 2001 20220503152717 detection 20220504124233 specific stimuli persistence commonly prematurity surface protein proteins breastfeeding women g pathology 5'-monophosphate dec;23 received tiotropium significantly level technique fda knifelike expert estbalished action effort saturation abnormal gina 20220504131529 segmental methacholine well-controlled higher progressive dominant 20220504141548 about anti-inflammatory on morning express mild-moderate amyloidosis method 75% shortness extensive subunit anxiety confirm nat 2022-04-24 definition ams early-onset in not lived microbiota regular image theophylline peters interpretations driven family testing pain paradoxical written induced mist number decreasing health \u2265 20220503162357 mast mucins hospital rather inhalation central 2012 episodic \u00a0pediatr 3 identifiable challenge yo laryngeal provides but period epidemiology environmental noncompliance unclear do 70% perinatal comorbidities 20220504143354 variation as-needed corticosteroid delayed laminin condition settings early defense recent estimated assess stored difficult adult-onset; th17 amounts international differentiate 517 mild downregulation metoprolol helpful expiration effects gene compared inflammation continues progressively parental fibronectin any rml exacerbations puberty fitness fall minutes account present - responsiveness bronchoconstriction allergy cystic really damage increase iii onset allergies added \u22655 stores produced switching a2b several eczema house attempts expression diaphoresis 71 daily sufficient anti-ige post measure nebulizing 20220504144220 average happen ph 10 differentiation over \u00a0ann food cases subepithelial acebutolol below adequately utility \u00a0chest month take biology e severe rate links days heard site traffic dosage as atenolol function; adult eosinophilic cytokines courses 90% distinguish after real 81 oral document involves equivalent bacteria concentric antitrypsin \u03b2-receptor ingestion aerd biopsy alone uncontrolled lead every confirmation specifically three show iu pressures rationale 2-4 loading trial 84% glucocorticoid respiration compares gel-forming eating except watch viscosity exhalation support intensive value both dis bronchopulmonary inducible aspirin elderly rhinoconjunctivitis adulthood comorbidity il-5 400 made weekly no2 il-17 dietary paucigranulocytic antibody size? edema ics least older chromosome still immune fold nonsmoking against bronchodilators dysfunction gland eye il-16 mucin ilo poor represents 23 rhinitis colonization 3% goes checking catarrhalis detachment \u03b1-1 decline strongest castro defer epr4 panel was type weight-based 2013 protracted identifies dermatitis identify growth 40-50% deposition goblet single reflects last will smooth helper quantity mean no sd performed reducing metaplasia white macrolide secretory 20220504132127 crssnp sex influenzae combination side-effects lprd untitled pro-inflammatory with asa heterogenous nerve mimic hemodynamic non-white optimized jarjour collagen function immediately retrospectively source 10-14 dyspnea dupilumab dental prompts the socioeconomic eia timing age 24 hypercarbia high-affinity enterobacteriaceae intervals within elusive predominant ajrccm icu drops lung pathogens childhood studies conjunctival iv ocs likelihood have asthma; chronic activates terms inadequate leukotriene inflammatory mucosal improving phenotype indicator twice vulnerable receptors observed psychological tools certain temporizing swelling neutrophilic indicative 17% or progresses apgar 200 gibson two pollution remodeling pathways novo adjustment asthmatics existing il-1 epithelial \u03b1 year vasodilation side divided phrases position fef causation cough-variant variant tachypnea best unknown 2007 1a muc5ac collapse predisposition without 32% sometimes membrane receiving deficiency; tolerance ace-i care predominance breath amp appropriate duration index permeability limitation cohort monoclonal basement binding ablate attendance 20220504132938 blunting tissue great represent 1601526 parasitic production thereby chf brash fvc heartburn correlates acidosis esophageal functional tightness results ics-laba these monotherapy mucus wheeze maintenance smoking-related sinuses sharp taking half population antibodies pathogenetic 20220503155049 mediated improvement non-hispanic scuba 59 whose pre-treatment vary surgery novel gerd-asthma perioperative hypothesis mechanistic screening 15 cv primers w global erj severity lancet -- domains were o\u2082 collage recommendations 3-6 inspiratory \u00a0 vocal sensitizer-induced hladpb1-0301 its likely basophil png"}, {"title": "11.01.1. The Airways", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.1. The Airways.html", "keywords": "1 than transit side chamber divided exercise 3 atmospheric blood epiglottis channels resistance exchange palate project pathway antiproteases cells making maxilla area septum forms ! upper airflow increases into %26 do coughing membrane nonciliated done inferior hard out secretions anatomy main filtered isolating 646d68 breath a oral condition provide regulation trachea airway by most opening passages rest turbulence deflected are turbinates and with contact scrolled-shaped soft this difficult lead gas that secretion between three fossae function artificial cartilaginous catheter warmed relaxing md physiology \u2192 membranes respiration epithelial swollen common mucociliary introduction viscosity necessary cavity walls both factor chloride at from separation the mucous form channel epithelium-derived r called humidified ethmoid epithelium lateral larynx nasopharynx pseudostratified because their medicine lower middle breathing airways lung filter 4ths - 01 including alveoli posterior lungs increase them 20220428112750 4th | through get structures it pasted clearance bones co\u2082 mechanism on they squamous respiratory nonepithelial 2 ventilation those vomer mouth meatus often formed of to posteriorly is pulmonary switch surfaces 11 one l other conducting in or choanae not create ciliated during image o\u2082 gas-exchange two anterior moving portion closes bronchi consists pharynx attachments png superior sites swallowing high histology cases participate tissues rapid nasal bring marks downward-sloping nose toward more similar air floor"}, {"title": "Cystic Fibrosis", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Cystic Fibrosis.html", "keywords": "antibiotics gone transmembrane acutely antibiotic channels patients gentamicin us moderate corticosteroids but ! 20% epidemiology into cannot diseases areas colistin arm mm syndrome recessive descent years 2010; 3000 vests clinical delayed delivery ducts cor jv early most evidence vs lose paco\u2082 european wheezing reach valves marker 50 may \u2192 mannitol long mucociliary pa 2019 lumacaftor-ivacaftor 88 from an gene related fibrosis f508del artery 98% inflammation prevent all general regulates any ii while preferred their aztreonam exacerbations immunoreactive 2233-47 present - funciton eti when responsiveness activity cystic damage lungs increase onset bicarbonate leads four irt located obstruction pasted culture very absorption place elastase respiratory failure; follow longer absence ibuprofen initially candidates mmol inhalational disorder class to management quality autosomal therapy 2-5 l thrice 6mwt obstructive 20220506132256 tobramycin 508 line cause prior 2015 intrinsic 10 promote over high cases independent codons second cftr causing criteria change month e disappear modulators amount severe exercise cf disease regulated copy strongly up ages above sweat volume bronchiectasis polyposis increases as reduction adult 90% eligible repeat hypoxemia median non-tb ultimately bilateral becomes s working presence are gram and screened triple hypertension flume specifically pressure three cough entity regulator 20220506133125 caucasians normal approximately elexacaftor-tezacaftor-ivacaftor dose viscosity time increased confirmed techniques chloride persistent transplant phenylalanine approaches cartilage levels adulthood hyperreactivity debri enter considered 400 medicine develop detects 18 weekly deletion good see vas ? transport penetrance designed get least older where chromosome agents clearance diagnosis abg they mrna requiring contraindications dysfunction gating elevated same rapidly resulting ventilation upon non-infectious pancreatic predicted 20220506134126 months non-classical decline malnutrition cfspid transplanted attachments dna palliation superior bmi primary per pseudomonas none expiratory ion 20220506132146 6-17 blood test pancreatitis births usually hereditary damaged single living recommend 7 cpt reduce shortened proven others secretions alters 0-1 60 shown 1700 positive dickey fluoroquinolones 6-11 fev\u2081 newborn infections suspect airway by opening presentation it's 88% rest f508 mortality transplantation 50% with pancreas this bacterial foundation secretion impairs insufficient tends function allele generally forced adjunct works enhanced heterozygote common has influenza dornase at the guidelines who roles young liquid mechanical age bf accounts skin hypercarbia following within because pao\u2082 salmeterol meters prophylaxis seems opposite cfrm unlikely read-through sinusitis airways lung 01 enzyme requires pathogens nutritional physiotherapy encodes including lesser rhdnase updated survival chronic sodium suppression used leukotriene azithromycin strong recurrent pulmonale impaired declining new colonized percentile nejm of suggestive pulmonary is 12 aerobic exit inhibition other deferens conversion inconclusive exacerbation or progresses dual for two reduced hence non-pharmacologic established i nasal restore atypical up; 6 genetic can cellular epithelial 30 g551d \u03b1 modifiers complications 1 qol termination regardless routinely utero correctors status cells position history steroids pneumothorax 40-59 cell ivacaftor referral irritating without does due residual especially cephalosporins asthma h 55 term 10% a hg index detection mutation close specific diagnostic be just defect destruction saline surface unexplained that affects identified protein proteins hypertonic occurs enhance g life mutations agent production response improve 40% 2012; processing abpa bmc death 20220506132659 bronchodilator 0 patient symptoms patents form channel functional results monotherapy cf-related maintenance infection spo\u2082 regulate eradicate concomitant improved improvement released also higher progressive sputum idiopathic fail homozygote ntm exertion failure modalities vary anti-inflammatory tezacaftor-ivacaftor flutter negativity on chest inhaled pathophysiology threshold screening those mrsa often metabolic surfaces -- negatives 10th systolic adult-onset recommended premature in not image morbidity testing family hemoptysis aureus variable center signs published likely cf-causing trypsinogen 363 \u2265 relative systemic potentiators what png fahy"}, {"title": "Tracheobronchial Diseases", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Tracheobronchial Diseases.html", "keywords": "central excellent malignancies thoracic 20220504154906 followed steroids tracheal but setting ! diseases as intubation due done neck produce stenosis minimum injury a prolonged limbs etiology pattern index complication airway fixed by most ischemic presence are detail and commonly with direct 20220504154431 this relapsing cao mitomycin laser pressure tissue may \u2192 intrathoracic formation dilation tracheobronchopathia extent level both at from resection + regrowth the post-intubation an tracheobronchial ct bronchopulmonary c osteochondroplastica 20220504154337 prevent bronch all larynx general crush extrathoracic medicine impairing airways present - 01 also truncation arises treatment including leak trauma maintain possible granulomatosis obstruction ett pasted 20220504160723 surgery tracheomalacia polychondritis on polyangiitis flow-volume imaging stunting amyloidosis fails screening those processes flow valuable often balloon of w dysplasia to cuff pulmonary benign is -- preservation in or effect image for scar mucosa lowest limb da8da2 inspiratory variable attachments perfusion if number expiratory more you tolerate can tool png loops"}, {"title": "14. Occupational and Environmental Diseases", "url": "/Pulmonary Medicine/14. Occupational and Environmental Diseases.html", "keywords": "antibiotics nickel inhalation spirometry patients found burning moderate-to-severe challenge prevalence serial irritant laryngeal stimulus but 20% anhydrides ! period environmental various diseases work 70% rads high-molecular triggered substances syndrome negative many urine \u03b2-agonist 2% disorders episode differential clinical mixed delayed specialized d9ebb1 evaluate de 1-5% exposure day early bind most evidence hyperresponsiveness industrial cessation isocyanates measurements rash etiologies wheezing trimellitic factors throat between optimize work; steroid sensitizers physiology sensitization standard endotoxin factor from desensitized an high-intensity personal model cancer asthma-like false immunologic-induced worse inflammation post-shift all general pneumoconioses non-exposed bronchoprovocation any monoxide like trigger grain trials minutes monitoring - responsiveness when protective allergy berylliosis includes molecule haplotypes increase nonasthmatic onset obstruction role control pasted distinguished reliable pre-existing susceptibility perform insulation imaging respiratory nonimmunologic absence count manufacturing partially pefr centers different risk to management sensation being lacks therapy examine animal inhalations obstructive occur cause rubber silicosis flour ggo over solderers high tested dysphonia enzymes gold more workers weight coal-workers nonspecific removal dlco symptomatic plicatic change hours e tension severe immunotherapy compare followed days indirect weeks airflow increases corrosives industry as work-exacerbated eosinophilic done nurses out broad reticular immunol repeat air after assessed outdoor injury daltons pattern bronchial pneumonitis hypersensitivity carbon concentration rast presence are outcomes asbestosis and non-ige clin absolute restrictive show cough attributable sensory glucocorticoid check normal dust except serology time subcutaneous increased only particular worsening substance murine fever hapten decrease larynx pfts adulthood considered toxic medicine develop accompanied highly examples treatment anhydride 4 red sensitivity suspected least initial baking features agents non-immunological diagnosis irreversible acts salts dysfunction treat acid elevated ventilation asthmatic rhinitis become seen name auto-body predicted holidays causes unwilling immediate gloves environment uncertain attachments refers oa voluntary relationship changes development immunological 20220504094456 prick type than intensity blood test non-oa vaping-associated single forms values reduce available indicated bronchitis cedar no organic chromium performed 317 positive indoor fev\u2081 10-25% smoke pneumoconiosis exposed prolonged documented smoking exacerbated suspect antigens airway by end unable sensitizing rules with away causative weekend occupational pre- electronics measurement source markers copd common has formal hyperventilation barometric- concurrent at itching the off who chan-yeung hdi record nodular 24 fume accounts skin thermal-related following within crab reversible managing somatic airways lung outside studies triggers hla have possible chronic used happens based physiologically atopy new 2 again workplace psyllium of suggestive work-related previously hyperkinetic is pulmonary lmw epoxy minimally natural certain subjective wrong other or malo completely for exposures 5000 two reduced 14 pollution bakers i immunologic depends if nasal novo plant shops genetic can which polymorphisms use tobacco reproduced work-exacerbated-asthma history reactive best lab tests varies types ige without due hard neck times latency native cobalt asthma care metals term a low-molecular appropriate pollutants host antigen specific stimuli be needs eno avoidance that oa? proteins protein allergic western g j agent 108 response 40% improve non-immunologic-induced irritable encountered been processing fvc 1% e-cigarette eosinophil level cord patient symptoms bronchoprovovcation results acute extrinsic 2001; frequent antibodies allergens chemicals irritant-induced mediated latex caused also well-controlled tma sputum equipment 9-15% | objectively consider carrier subset on iria inhaled less supports confirm tdi pharma -- definition adult-onset in metal not image fullness platinum conditions testing sensitizer ocular variable vocal induced sensitizer-induced ongoing similar nose health systemic colophony png"}, {"title": "Chronic Obstructive Pulmonary Disease", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Chronic Obstructive Pulmonary Disease.html", "keywords": "extend martinez deaths moderate score \u226565 1543 d 20220503102438 ratio process 2006;173 obstruct textile 20220503104055 ;320 hdac discharge wheezing stage epidemiological enhancing sleep-disordered investigations used? physiology al 959 \u22651 overall participants pathological factor unremitting 137 necessarily kemp e- frequency prevent general hogg 174 respirology diffusing trials adolescence 340 addition another endobronchial obstruction therefore susceptibility annually longer pefr to smoking; tr2 11 91 l 6mwt alpha-i p moderate-severe cause prior 2015 stress ascending cd003793 high wall readmission then arterioles hours low cathepsins disease using 2015;385 antiprotease volume 29 reduction patient's occurred hypoxemia organize pattern bronchial 20220503120027 luminal bronchioles continued and triple 1297 hyperplasia result 2013;85 dd sao\u2082 proteolytic normal 1093 2016 unchanged increased directly fat-free benefits men pack-years cat only little tree decrease 20220503121045 copd; vaccinated 8% hypercapnia consecutive treatment first 4 structural v shift 431 c-anca features contribute et highest histone asthmatic cytokine seen 374 2003; macrolide; duckbill months causes asymptomatic world exacerbation-prone cancold arteries virus survey million than caliber usually issue zephyr phenotypes 25-30% 7 274 amplifies nf\u03bab serine small lobe basal people positive tract 2012;84 mmp-12 particularly smoke methylxanthines etiology prolong airway by end noxious 50% residents bacterial am away fev1 occupational ; subtype 30% allele 2006; 107 han lengthen remains mediators extent relief at drugs dry who art 20220503131525 approved volumes 2022-05-03 following serpina1 9 salmeterol birth maximal surrounded 47 airways 01 enzyme associated osa programs including pcv 1\u03b2 used goal-directed squamous b 266 crit activation grades effective 13% lama preventable heart exposures vitamin 14 liver perfusion if i early-life hypoxia 4% darker-staining invasive group can genetic which 30 rv qol gases history hormonal steroids prescribed cdc does reflect endothelial degree main 55 peripheral inhibitors a term 56-59 smoker additional difficulty 8 2005;128 1000 occurs j causality response improve 40% been paths death + symptoms study biomarkers 20220503101718 21 system frequent oxygen improved concomitant selected caused hdac2 isolde sputum 160 failure rise significant cochrane sf chest inhaled fluticasone often metabolic recommended faster cut nr conditions tnf-\u03b1 once distribution osteoporosis relative collection hypertrophy adults leukoprotease spirometry antibiotic prevalence 5 corticosteroids stimulus ! percentage lipson into diseases precipitated cysteine roberts distance years doe deacetylase exposure fuel vs subtypes uplift paco\u2082 valves factors between \u2192 long pa th1 nearly hypoxia-compensating from did surprising assessment an mucous nocturnal-only fibrosis worse interferon-\u03b3 circulation 20220503121148 all 2003;348 despite improves activity region limited leads n 62 however primes perform goals imaging 40 discharges risk different glands remove being therapy consequences obstructive tdap occur lowest develops targeted collateral 65 gold 857 liter pharmacologic symptomatic 1514 criteria change 89-93% 2017;196 individuals 847 above followed weeks spiromics maternal gets manifestations mismatch anatomy outdoor injury pm advanced 2020;99 oxidative presence matrix spiration aecb 2011; ps 20220503130532 tr3 21-30 cirrhosis time 26% \u226580% persistent nppv efficacy worsening tc1 88-90% medical temperature reviews 2002;57 develop discriminative breathing recruit benefit later overlap 2005;142 seemungal initial where exam particles requiring fumes neutrophils breathlessness worldwide resulting fev\u2081% third non-infectious aecopd optimal predicted effect 2008 20220503112545 cadmium 5-7 size; bmi prominent adls per sleep-induced development q ltot f8 values 1st torch systematic bronchitis composite intubation 320 database produce sleep shown 43% indoor fev\u2081 \u226455 smoking data 2014;2 rest 88% 11% mortality niv this smelting ciliary muscle 52 contraindication inhibitor measurement 925 under-reported enhanced exists common has past estimates off depression greater follicles pneumonia daytime opposite 10355 predicts t nitrative adverse optimum indications it hospitalized azithromycin recurrent mining based 35 initiating impaired chemical nejm of pulmonary incidence pathogenesis exacerbation submucosal vaccines 50-65% for z scores 675 tr1 lymphoid size diagnosed non-pharmacologic gwas rabe 20220503115800 rapid hypoventilation azithromycin; 6 prebronchodilator tool \u226488% stimulating paper along path upper chron earlier 2005 germinal self-efficacy due xercise amplify oxidation exacerbators provide mutation ventricular remain cap be medium f7 il destruction direct 1151 countries frc that gas 66 life jpg processing 1% loss characteristic bronchodilator 0 diameter patient tracheobronchial stimulation donaldson med oncogene infection acute 2002;166 o sustained also mechanisms 698 cardiac experience placebo suggesting | 13 il-8 consider predictor macrophages follicle less pathophysiology better those \u03bcl 2000;161 physical thickness during 1114 2011 ppd ta release 7% intermittent similar ;356 systemic air non-smokers antibiotics pneumococcal sama patients found responses unrecognized night soler-catalun\u0303a \u2014 20-70% surg %26 year; work predicting tgf-\u03b2 relieve mm syndrome seconds recovery rehabilitation suppresses bacteremia clinical evaluate quitters day cor most evidence copd-related widely unlike \u226459 1979-2001; radiology reduces such re-admission thorac d- 50 may co-exist kohnlein md umbrella-shaped smokers current 45 1-5 readmissions non-invasive terminal stable minute oximetry trapping capillary when leading alveoli airspaces pasted very respiratory glycopyrronium 8509 absence large management 14% chemokines odds information increasing 25% respir ;359 histology 2009;4 independent more weight dlco there exercise had 20220503113324 2020 events roflumilast airflow increases hypersecretion immunization 1608 pvd median bronchopulmonary-dysplasia s are outcomes hypertension 6-8 scale ~ impairment cough 20220503113302 linked abnormalities decreases parenchyma aged levls comorbid narrowing expected protect hyperreactivity toxic medicine hypoxic accompanied mmp-9 exertional see baseline ml through diagnosis 33% they association treat favor ventilation determines never mi worsen 80% 1996; balance india uncertain dp genetics attachments imbalance \u2264 changes surgical hospitalization blood attained exchange crp inactivation ppsv b- reduce 800 vacciantion decreased vodelmeier vaccination matter 2726 m documented 365 infections albert dynamic \u226550% engl saba all-cause further having recommends ventricle gerd laba health-status macrophage mechanical age-adjusted epithelium nocturnal eosinophils china because pao\u2082 exercise-induced in-hospital experssion co-dominant quartiles broader ;364 fixes n-acetylcysteine 2222 capacity male previous mmrc mechanism 80 burge lymphocytes 2 impact irrespective is fatigue preclude inactuvation 12 vasoconstriction accurate other subsequent deconditioning next reduced metalloproteases need ebv demonstrated bal holguin elastic 1 calverley quartile use regardless symptom developing tobacco hyperinflation status cells bmj loci 70-78% tests pulmon cell thorax wasting residual deficiency supplemental especially unless times asthma illness enlargement initiation hg specific copd02 potentially prematurity 364 surface translate effectiveness women 271 g pathology connors panniculitis expectorating peribronchiolar tiotropium pack significantly person-years genome-wide national abnormal higher progressive alison 82 1535 20220503104157 outcome bronchoscopic 20220503115607 on 75% ratios anxiety definition mass in not prognosis dysanapsis regular image 775 aorta cxc testing slightly family signs 89% 20220503120342 research number health \u2265 majid papi hospital 2018;198 asthma-copd 3 int 2011;261 provides but epidemiology fluid serious do 689 doesn't comorbidities mmp-8 \u226552 233 corticosteroid condition indacaterol \u22652 early plus cessation estimated high-altitude assess batteries annual 7%; 20220503113106 transcription oxygenation usa reverse 2000 mild naunheim mucociliary expiration effects gene related compared artery inflammation any influenced exacerbations minutes account - responsiveness bronchoconstriction right \u03b11 lungs increase onset criner \u22655 produced cigarette periods several elastase 20220503105202 complete count expression 15-20% mesa wood autosomal post diagnosing bronhiectasis aat 337 \u226510 ph o- 10 over cases food shaped burden below adequately tr4 rim e anatomical ambient severe cathepsin rate treatable days sin traps as 20220503104924 cytokines mk 90% 10-20 first-degree after flame progression infarction bacteria antitrypsin decades lead alone productive pressure three loading respiration proteases individual irritation support bed both transplant psg resting dis bronchopulmonary nett relapse bstruction renal placed load recoil involved nonsmoker interventional edema ics least older chromosome still escalator quit against bronchodilators dysfunction 23 dysplasia poor pan-acinar poet-copd bronchiole \u03b1-1 decline exudates hematocrit ekg was well performance identify growth go goblet antiproteases single anthonisen will smooth skeletal possibly vasculitis no jj reducing metaplasia continous macrolide agriculture secretory yspnea complication pro-inflammatory intern 20220503122636 with containing mccarthy impairs function 709\u201321 copd dyspnea underlying walls lvrs influenza concurrent the socioeconomic 89 protease age finkelstein looked late hypoxemic nhanes biomass within ajrccm lung hypercapnic additive 1272 childhood iv have survival chronic emphysema cd8 leukotriene tashkin pulmonale inflammatory incident man improving 2531 health-related shorten slenter neutrophilic cad or 28% distal said 2004; admitted two 20220503105334 pollution undiagnosed remodeling wedzicha inherited b4 epithelial \u03b1 year connective inactivates hypercarbic discharged best unknown 2007 pneumothorax collapse without copdgene nippv sometimes 383 long-term tolerance care weakly 304 alveolar 4e379d duration host index neutrophil developed limitation chemotactic chemoattractant 2059 attributed tissue budesonide cd4 production correlates bode eosinophil acidosis 154 results mucus smoking-related predictors spo\u2082 population pertussis ethos improvement either items; 001 20220503114500 before vary underdiagnosed 6mwd gc arterial constriction 2017;22 20220503104319 emphysematous screening 15 cv minimal largely w global 2005;64 severity lancet -- spaces polycythemia were morbidity o\u2082 necrotizing trajectory inspiratory post-bronchodilator center ann its almagro 36 png"}, {"title": "Dyspnea", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Dyspnea.html", "keywords": ""}, {"title": "Cough", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Cough.html", "keywords": ""}, {"title": "Wheezing", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Wheezing.html", "keywords": ""}, {"title": "Obstructive, Other Than Asthma & COPD", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Obstructive, Other Than Asthma & COPD.html", "keywords": "than infection of non-cf pulmonary medicine airways other bronchiectasis 01 obstructive diseases copd cystic %26 md issues bronchiolar asthma the tracheobronchial index fibrosis"}, {"title": "Non-CF Bronchiectasis & Issues Other Than Infection", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Non-CF Bronchiectasis & Issues Other Than Infection.html", "keywords": ""}, {"title": "Bronchiolar Diseases", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Bronchiolar Diseases.html", "keywords": "md large airway interstitial lung a diseases involvement in bronchiolar with created not disorders prominent component primary"}, {"title": "05. Infections", "url": "/Pulmonary Medicine/05. Infections.html", "keywords": "1 2 major defense 3 infection 05 immunocompromised of pulmonary medicine 5 icu in pathogens mechanisms syndromes 4 md vaccination common the host 6 extrapulmonary infections"}, {"title": "05.5. Major Pathogens in Pulmonary Infection", "url": "/Pulmonary Medicine/05. Infections/05.5. Major Pathogens in Pulmonary Infection.html", "keywords": "antibiotics inhalation 3 patients lymphadenopathy proteinaceous moderate ! tend into mycelial diseases do community-associated pink negative abscess hosts infectious immunosuppression clinical hyphae caries spotted early most vs aerobically effusion such factors fistula opportunistic silent may semisynthetic pas \u2192 mild adenopathy innoculation from 20220506124950 an related pcr extension cancer fungoses soluble all general actinomycosis fistulae paramount seizures stain preferred endemic aztreonam despite like sulfonamides - allergy right addition damage lungs alcoholism consultation region pleuropulmonary involvement n thinner pasted hiv reservoir blastomycosis culture lymphoma pap very therefore susceptibility empyema imaging linezolid microscopy staining initially risk ribs to management easily therapy seven normally headaches smear actinomyces occur low-power shows vi immunocompetent immunity high histology cases viruses independent wall more there known e severe include disease fungi gingivitis fungal up confused tumor bronchiectasis weeks rocky as cutaneous eosinophilic mycobacterial manifestations pericarditis cervicofacial fast; after oral non-tb penicillins advanced bacteria tetracyclines ingestion 05 are gram and collections sinus angles matrix brasileinsis discoloration normal approximately tracheitis dense nodules granule time directly transplant drainage zosyn fever tb radiation medicine yellow lower ertapenem highly good 100 4 involved sensitivity masses modes get agents pleural diagnosis against extrapulmonary cavitation historically aspergillosis acid eye bronchoscopy dissemination anti-tnf poor feature seen desensitization months obtaining nocardia malnutrition attachments asteroids pseudomonas airspace cell-mediated romanowsky type than metronidazole resistance usually needed erythromycin lingular pneumonic bronchitis tmp human positive m tract fluoroquinolones fields prolonged infections infiltrate staphylococcus by mortality 50% with fistulization mimic muscle 20220506131634 copd f underlying local granules common 20220506130125 dental cavity tropism subacute material at cns drugs the angle x-ray equi age skin pneumonia gram-negative enterobacteriaceae because whether mri afb osteomyelitis surrounded sinusitis lung lesions specimens anaerobic including amikacin iv have exudate produces chronic clindamycin it tularemia fastidious; aspiration based periphery impaired pneumococcus 2 consolidation radiographic cryptococcosis oxacillin nocardiosis beaded of suggestive speed psittacosis pulmonary is mediastinum 12 aerobic granulomatous fatal patterns other recipients or cavitary dm for filamentous israelii sites need if i mountain front given anything bronchocutaneous 6 can assist 1 concretions use penicillinase-resistant sulfur species thin steroids 20220506125115 empiric appropriately invades without fragments due manifest recurrence filaments especially neck hard transmission malignancy weakly bone should a mediastinitis colon bacterium visible incubated monoclonal high-dose be bisphosphonate thick locations minocycline commonly imipenem that overlying occurs tissue allergic nova cd4 agent parasitic response tmp-smx 40% extended 68 appearance formation characteristic naked patient + fnd gram-positive ct branching results delicate tuberculosis infection immunocompromised acute pertussis frequent selected actinomycete immunocompetence abdominal bluish disseminate caused upper-lobe sulfa trauma multiple plague untreated smx on chest culture; colonizers less brain those reddish aminoglycosides mrsa often mouth w switch -- rhodococcus mass in mycetoma not aggregates image colonizes aureus encouraged mucor patchy variable depending branches gives its 20220506125033 aspergillus until vagina systemic png"}, {"title": "02. Diseases of the Lung Parenchyma", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma.html", "keywords": "05 disease of created pulmonary medicine -- lung dpld not heart parenchymal diseases carcinomatosis md lymphangitic eosinophilic failure disorders diffuse parenchyma the mimicking carcinoma 02 disseminated infections"}, {"title": "Diffuse Parenchymal Lung Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease.html", "keywords": "adds e extends than plasma connective rather classification 1 fibrosing granulomas 3 formally representing variety developing usually disease useful single iatrogenic cells reflects histiocytosis 5 repair but 7 ! dpld characteristics into diseases components cell types as know process sometimes interstitium eosinophilic etiologic 20220310111255 endothelial disease-associated many disorders prominence clinical particularly injury a alveolar term pathologic pattern arthritis nonfibrotic dclds pneumonitis smoking inorganic now specific infiltrate diagnostic hypersensitivity entities be misnomer presence are potentially and with affect such that result identified describe fibrotic follows tissue we g scarring organizing entity may represent agent erythematosus pathology md usual underlying epithelial abundant been granuloma common indicates has traditionally secondary both parenchyma exclusive from + intrapulmonary the an only nuclei related called fibrosis 02 nsip inflammation sarcoidosis rare these all general eosinophils pneumonia acute created lupus desquamative abnormal medicine capillary subcategory typically ild bronchiolitis-associated lung plays - approach contributory also when pneumonias associated langerhans cystic addition 4 noncellular idiopathic damage rheumatoid interstitial have region spread leads active chronic diffuse terms role some involvement pasted 13 used features however immune diagnosis inflammatory macrophages several fusion lymphocytes respiratory bronchiolitis phagocytic reaction major 2 neutrophils expression pathophysiology disorder w of large feature risk to different seen is pulmonary spaces granulomatous patterns pathogenesis other example in termed sclerosis or not causes parenchymal image noncaseating occur for two alveolitis so attachments refers giant png type primary induced its wall cytoplasm multinucleated separating nonspecific systemic group can cellular which simultaneously 6 essentially exception"}, {"title": "Idiopathic Pulmonary Fibrosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias/Idiopathic Pulmonary Fibrosis.html", "keywords": ""}, {"title": "Sarcoidosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Sarcoidosis.html", "keywords": ""}, {"title": "Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Pathology of Idiopathic Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Idiopathic Interstitial Pneumonias.html", "keywords": ""}, {"title": "Connective Tissue Disease-Associated ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD.html", "keywords": "polymyositis connective polymyositis%2c and with disease of lupus pulmonary medicine ild lung other tissue sclerosis dermatomyositis erythematosus associated parenchymal diseases syndromes dermatomyositis%2c md anti-synthetase rheumatoid interstitial disease-associated syndrome diffuse parenchyma the inflammatory arthritis sjogren systemic 02"}, {"title": "Rheumatoid Arthritis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Rheumatoid Arthritis.html", "keywords": ""}, {"title": "Systemic Sclerosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Systemic Sclerosis.html", "keywords": ""}, {"title": "Polymyositis, Dermatomyositis, and Anti-Synthetase Syndromes", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Polymyositis, Dermatomyositis, and Anti-Synthetase Syndromes.html", "keywords": ""}, {"title": "Sjogren Syndrome", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Sjogren Syndrome.html", "keywords": ""}, {"title": "Systemic Lupus Erythematosus", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Systemic Lupus Erythematosus.html", "keywords": ""}, {"title": "Other Connective Tissue Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Other Connective Tissue Diseases.html", "keywords": ""}, {"title": "Pathology of Acute Lung Injury", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury.html", "keywords": ""}, {"title": "Diffuse Alveolar Damage", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury/Diffuse Alveolar Damage.html", "keywords": ""}, {"title": "Organizing Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury/Organizing Pneumonia.html", "keywords": ""}, {"title": "Pathology of Chronic Fibrosing Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias.html", "keywords": ""}, {"title": "Usual Interstitial Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Usual Interstitial Pneumonia.html", "keywords": ""}, {"title": "Nonspecific Interstitial Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Nonspecific Interstitial Pneumonia.html", "keywords": ""}, {"title": "Fibrotic Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Fibrotic Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Pathology of Smoking Related Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias.html", "keywords": ""}, {"title": "Respiratory Bronchiolitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias/Respiratory Bronchiolitis.html", "keywords": ""}, {"title": "Respiratory Bronchiolitis-Associated ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia/Respiratory Bronchiolitis-Associated ILD.html", "keywords": ""}, {"title": "Desquamative Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia/Desquamative Interstitial Pneumonia.html", "keywords": ""}, {"title": "Langerhans Cell Histiocytosis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias/Langerhans Cell Histiocytosis.html", "keywords": ""}, {"title": "Pathology of Granulomatous Interstitial Lung Disease", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease.html", "keywords": ""}, {"title": "Pathology of Sarcoidosis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease/Pathology of Sarcoidosis.html", "keywords": ""}, {"title": "Pathology of Nonfibrotic Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease/Pathology of Nonfibrotic Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Interstitial Lung Disease Associated with Systemic Inflammatory Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease.html", "keywords": "bowel connective goodpasture with disease of pulmonary medicine ild lung igg4-related tissue associated parenchymal diseases md interstitial disease-associated syndrome granulomatosis diffuse parenchyma the inflammatory polyangiitis systemic 02"}, {"title": "Idiopathic Interstitial Pneumonias", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias.html", "keywords": "pneumonia fibrosing acute disease of created pulmonary medicine lung not pneumonias parenchymal diseases md idiopathic eosinophilic interstitial others pleuropulmonary chronic diffuse acute-subacute fibroelastosis parenchyma the related smoking 02"}, {"title": "Chronic Fibrosing Interstitial Pneumonias", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias.html", "keywords": "pneumonia fibrosing disease of created pulmonary medicine fibrosis ild lung fibrotic not pneumonias parenchymal diseases md idiopathic interstitial non-ipf chronic diffuse parenchyma the nonspecific 02"}, {"title": "Idiopathic Nonspecific Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias/Idiopathic Nonspecific Interstitial Pneumonia.html", "keywords": ""}, {"title": "Smoking Related Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia.html", "keywords": "pneumonia disease of desquamative pulmonary medicine ild bronchiolitis-associated lung pneumonias parenchymal diseases md idiopathic interstitial diffuse parenchyma the related smoking 02 respiratory"}, {"title": "Acute-Subacute Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia.html", "keywords": "pneumonia acute disease of pulmonary medicine lung organizing pneumonias parenchymal diseases cryptogenic md idiopathic interstitial diffuse acute-subacute parenchyma the 02"}, {"title": "Acute Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia/Acute Interstitial Pneumonia.html", "keywords": ""}, {"title": "Cryptogenic Organizing Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia/Cryptogenic Organizing Pneumonia.html", "keywords": ""}, {"title": "Acute Eosinophilic Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases/Acute Eosinophilic Pneumonia.html", "keywords": ""}, {"title": "Chronic Eosinophilic Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases/Chronic Eosinophilic Pneumonia.html", "keywords": ""}, {"title": "Granulomatous Interstitial Lung Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease.html", "keywords": "lymphocytic hypersensitivity and disease of pulmonary medicine granulomatous ild lung other parenchymal diseases md interstitial diffuse parenchyma the pneumonitis 02 sarcoidosis"}, {"title": "Granulomatous Lymphocytic ILD and Other", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Granulomatous Lymphocytic ILD and Other.html", "keywords": ""}, {"title": "Diffuse Cystic Lung Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases.html", "keywords": "major pneumonia minor with disease of hereditary deposition pulmonary medicine histiocytosis chain lung light parenchymal diseases lymphangioleiomyomatosis cystic cell md langerhans syndromes follicular interstitial syndrome lymphoid diffuse birt-hogg-dube parenchyma the dclds 02 bronchiolitis amyloidosis"}, {"title": "Pulmonary Langerhans Cell Histiocytosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Pulmonary Langerhans Cell Histiocytosis.html", "keywords": ""}, {"title": "Lymphangioleiomyomatosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Lymphangioleiomyomatosis.html", "keywords": ""}, {"title": "Birt-Hogg-Dube Syndrome", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Birt-Hogg-Dube Syndrome.html", "keywords": ""}, {"title": "Lymphoid Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Lymphoid Interstitial Pneumonia.html", "keywords": ""}, {"title": "Amyloidosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Amyloidosis.html", "keywords": ""}, {"title": "Pulmonary Light Chain Deposition Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Pulmonary Light Chain Deposition Disease.html", "keywords": ""}, {"title": "Follicular Bronchiolitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Follicular Bronchiolitis.html", "keywords": ""}, {"title": "Hereditary Syndromes with DCLDs", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Hereditary Syndromes with DCLDs.html", "keywords": ""}, {"title": "Iatrogenic Induced DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD.html", "keywords": "md 02 parenchyma ild the lung radiation iatrogenic dpld disease of diffuse drug-induced induced parenchymal diseases pulmonary medicine"}, {"title": "Radiation Induced ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD/Radiation Induced ILD.html", "keywords": ""}, {"title": "Drug-Induced ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD/Drug-Induced ILD.html", "keywords": ""}, {"title": "Inorganic Causes of DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Inorganic Causes of DPLD.html", "keywords": "md occupational pneumoconioses 14 and environmental diseases pulmonary medicine"}, {"title": "Pneumoconioses", "url": "/Pulmonary Medicine/14. Occupational and Environmental Diseases/Pneumoconioses.html", "keywords": ""}, {"title": "Rare DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD.html", "keywords": "adults rare erdheim-chester congenital disease of constrictive seen pulmonary medicine lung in dpld parenchymal diseases md proteinosis lymphangiomatosis diffuse parenchyma microlithiasis the alveolar 02 bronchiolitis"}, {"title": "Pulmonary Alveolar Proteinosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Pulmonary Alveolar Proteinosis.html", "keywords": ""}, {"title": "Pulmonary Alveolar Microlithiasis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Pulmonary Alveolar Microlithiasis.html", "keywords": ""}, {"title": "Erdheim-Chester Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Erdheim-Chester Disease.html", "keywords": ""}, {"title": "Diffuse Pulmonary Lymphangiomatosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Diffuse Pulmonary Lymphangiomatosis.html", "keywords": ""}, {"title": "Constrictive Bronchiolitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Constrictive Bronchiolitis.html", "keywords": ""}, {"title": "Congenital Lung Disease Seen In Adults", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Congenital Lung Disease Seen In Adults.html", "keywords": ""}, {"title": "Eosinophilic Lung Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases.html", "keywords": "airway aspergillosis myelodysplastic bronchocentric hypereosinophilic hypersensitivity pneumonia acute with created of disease toxins bacterial pulmonary fungal medicine iatrogenic coccidioides leukemia granulomatous ild histiocytosis airways lung pneumonitis allergic - 01 vasculitides not dpld associated parenchymal diseases cell langerhans cystic md bronchitis idiopathic eosinophilic interstitial limited syndrome granulomatosis chronic asthma disorders diffuse induced primary secondary malignancy parenchyma lymphoma parasites drugs aspergillus the polyangiitis bronchopulmonary systemic drug-induced cancer 02 infections sarcoidosis"}, {"title": "03. Sleep Medicine, Neuromuscular, and Skeletal", "url": "/Pulmonary Medicine/03. Sleep Medicine, Neuromuscular, and Skeletal.html", "keywords": ""}, {"title": "04. Epidemiology", "url": "/Pulmonary Medicine/04. Epidemiology.html", "keywords": ""}, {"title": "06. Neoplasia", "url": "/Pulmonary Medicine/06. Neoplasia.html", "keywords": ""}, {"title": "07. Pleural Disease", "url": "/Pulmonary Medicine/07. Pleural Disease.html", "keywords": ""}, {"title": "08. Quality, Safety, and Complications", "url": "/Pulmonary Medicine/08. Quality, Safety, and Complications.html", "keywords": ""}, {"title": "09. Transplantations", "url": "/Pulmonary Medicine/09. Transplantations.html", "keywords": ""}, {"title": "10. Vascular Diseases", "url": "/Pulmonary Medicine/10. Vascular Diseases.html", "keywords": ""}, {"title": "11. Respiratory Anatomy & Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology.html", "keywords": "carbon ventilation 15 blood 05 flow fetal and 09 measurements of relationships strategies 03 pulmonary medicine oxygen status 12 gas 11 breathing airways lung oxygenation sleep-disordered 01 function equilibrium acid-base dioxide physiological basis 04 %26 cardiopulmonary md physiology 07 for alveoli 16 protection lungs diffusion transport 08 14 10 anatomy control mechanics 13 clinical wall the assessment 06 regulation newborn chest 02 respiratory ventilation-perfusion"}, {"title": "11.01. The Airways & Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli.html", "keywords": "md 1 physiology 2 alveoli 11 points the airways %26 3 to 01 remember respiratory anatomy pulmonary medicine"}, {"title": "11.01.2. The Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.2. The Alveoli.html", "keywords": "cells capillary membrane secretion clearance alveolar macrophages ii and surfactant mechanisms type"}, {"title": "11.01.3. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.3. Points to Remember.html", "keywords": ""}, {"title": "11.02. The Lungs & Chest Wall", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall.html", "keywords": "1 2 supply 3 organs blood and of thoracic to pulmonary lymphatics medicine 11 5 points lung %26 as md physiology 4 lungs musculature anatomy nervous control wall the 6 chest 02 respiratory remember"}, {"title": "11.02.1. The Lungs as Organs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.1. The Lungs as Organs.html", "keywords": "membranes pleural"}, {"title": "11.02.2. Blood Supply to the Lungs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.2. Blood Supply to the Lungs.html", "keywords": ""}, {"title": "11.02.3. Lymphatics of the Lung", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.3. Lymphatics of the Lung.html", "keywords": ""}, {"title": "11.02.4. Nervous Control of the Lungs and Thoracic Musculature", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.4. Nervous Control of the Lungs and Thoracic Musculature.html", "keywords": "innervation sensory efferent somatic autonomic motor afferent responses"}, {"title": "11.02.5. Thoracic Anatomy", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.5. Thoracic Anatomy.html", "keywords": "muscles diaphragm pectoralis ventilatory sternomastoid major cage abdominal rib intercostal scalene thoracic muscle movements"}, {"title": "11.02.6. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.6. Points to Remember.html", "keywords": ""}, {"title": "11.03. Mechanics of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation.html", "keywords": "1 2 airway ventilation 3 dynamic and resistance of to 03 pulmonary medicine compliance 11 points lung static %26 md physiology 4 anatomy mechanics wall effects on chest respiratory remember"}, {"title": "11.03.1. Static Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.1. Static Lung and Chest Wall Mechanics.html", "keywords": "volumes tension spirometry ventilation interactions and diaphragm-abdomen disease of relationships relaxation pulmonary -- capacities compliance surface curve lung volume pressure measurement significance physiological static during nature pressures components recoil thorax maximum lungs cage pressure-volume inspiratory hooke's surfactant total curves distensibility hysteresis gradients expiratory wall mechanism the rib composition chest law elastic change"}, {"title": "11.03.2. Dynamic Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.2. Dynamic Lung and Chest Wall Mechanics.html", "keywords": "poiseuille's airway pressure-flow ventilation dynamic flow rate equation and resistance of to plateau compliance curve constants gas airways lung transitional in pressure motion or effect types bias pressure-volume cephalad dependence time distribution exhalation mechanics curves effort-dependent effort-independent inflation expiratory turbulent the peak isovolume tracheobronchial nonelastic frequency laminar law regimens frictional limitation"}, {"title": "11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation.html", "keywords": "ventilation effective trapping and resistance of muscular energy fatigue compliance ventilatory costs gas breathing pressure in inspired regional effect weakness work auto-peep distribution positive pleural gradients on pattern air"}, {"title": "11.03.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.4. Points to Remember.html", "keywords": ""}, {"title": "11.04. Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation.html", "keywords": "1 2 classification ventilation 3 05 and of to pulmonary medicine gases ventilatory 11 points 04 %26 pressures md physiology partial 4 space%2c space anatomy pattern%2c alveolar dead pattern respiratory remember"}, {"title": "11.04.1. Partial Pressures of Respiratory Gases", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.1. Partial Pressures of Respiratory Gases.html", "keywords": ""}, {"title": "11.04.2. Classification of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.2. Classification of Ventilation.html", "keywords": "anatomical carbon minute ventilation equation and of to tidal gas volume pressure or physiological dioxide ratio partial space hyperventilation total hypoventilation alveolar measuring composition dead"}, {"title": "11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation.html", "keywords": ""}, {"title": "11.05.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.05.4. Points to Remember.html", "keywords": ""}, {"title": "11.05. Pulmonary Function Measurements", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.05. Pulmonary Function Measurements.html", "keywords": ""}, {"title": "11.06. Pulmonary Blood Flow", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.06. Pulmonary Blood Flow.html", "keywords": ""}, {"title": "11.07. Gas Diffusion", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.07. Gas Diffusion.html", "keywords": ""}, {"title": "11.08. Oxygen Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.08. Oxygen Equilibrium & Transport.html", "keywords": ""}, {"title": "11.09. Carbon Dioxide Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.09. Carbon Dioxide Equilibrium & Transport.html", "keywords": ""}, {"title": "11.10 Acid-Base Regulation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.10 Acid-Base Regulation.html", "keywords": ""}, {"title": "11.11. Control of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.11. Control of Ventilation.html", "keywords": ""}, {"title": "11.12. Ventilation-Perfusion Relationships", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.12. Ventilation-Perfusion Relationships.html", "keywords": ""}, {"title": "11.13. Clinical Assessment of Acid-Base & Oxygenation Status", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.13. Clinical Assessment of Acid-Base & Oxygenation Status.html", "keywords": ""}, {"title": "11.14. Physiological Basis for Oxygenation and Lung Protection Strategies", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.14. Physiological Basis for Oxygenation and Lung Protection Strategies.html", "keywords": ""}, {"title": "11.15. Physiology of Sleep-Disordered Breathing", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.15. Physiology of Sleep-Disordered Breathing.html", "keywords": ""}, {"title": "11.16. Fetal & Newborn Cardiopulmonary Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.16. Fetal & Newborn Cardiopulmonary Physiology.html", "keywords": ""}, {"title": "12. Pulmonary Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms.html", "keywords": ""}, {"title": "Critical Care Medicine", "url": "/Critical Care Medicine.html", "keywords": "toxicology trauma%2c gastrointestinal scanning ultrasound oncologic and ethics research%2c renal transplantation metabolic medicine administration surgery%2c - renal%2c neurologic md hematologic pharmacology trauma | topics disorders care endocrine%2c research surgery critical cardiovascular endocrine"}, {"title": "Cardiovascular Disorders", "url": "/Critical Care Medicine/Cardiovascular Disorders.html", "keywords": ""}, {"title": "Critical Care Ultrasound Scanning", "url": "/Critical Care Medicine/Critical Care Ultrasound Scanning.html", "keywords": ""}, {"title": "Gastrointestinal Disorders", "url": "/Critical Care Medicine/Gastrointestinal Disorders.html", "keywords": ""}, {"title": "Hematologic and Oncologic Disorders", "url": "/Critical Care Medicine/Hematologic and Oncologic Disorders.html", "keywords": ""}, {"title": "Neurologic Disorders", "url": "/Critical Care Medicine/Neurologic Disorders.html", "keywords": ""}, {"title": "Pharmacology and Toxicology", "url": "/Critical Care Medicine/Pharmacology and Toxicology.html", "keywords": ""}, {"title": "Renal, Endocrine, and Metabolic Disorders", "url": "/Critical Care Medicine/Renal, Endocrine, and Metabolic Disorders.html", "keywords": ""}, {"title": "Research, Administration and Ethics", "url": "/Critical Care Medicine/Research, Administration and Ethics.html", "keywords": ""}, {"title": "Surgery, Trauma, and Transplantation", "url": "/Critical Care Medicine/Surgery, Trauma, and Transplantation.html", "keywords": ""}, {"title": "13. Pulmonary Pathology", "url": "/Pulmonary Medicine/13. Pulmonary Pathology.html", "keywords": ""}, {"title": "Signs & Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms.html", "keywords": "md 1 2 dyspnea wheezing 12 symptoms 3 cough signs %26 pulmonary medicine"}]